LGI1 and movement disorder: Anti-NMDAR: seizures (73%), psychiatric symptoms (92%), movement disorder (45%), autonomic dysfunction (39%)  Anti-Lgi1: seizures (76%), psychiatric symptoms (57%), movement disorder (11%), autonomic dysfunction (12%)